Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

AU Dignass, S Stoynov, AE Dorofeyev, GA Grigorieva, E Tomsova, I Altorjay, D Tuculanu, I Bunganic, J Pokrotnieks, L Kupcinskas, R Greinwald, R Mueller

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberSa1217
Pages (from-to)S233
Issue number5, Suppl.1
Publication statusPublished - May 2013
Externally publishedYes
EventAnnual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2013) - Orlando, United States
Duration: 18 May 201321 May 2013

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this